"Interferon Type I/pharmacology"[MeSH] - Search Results

Year	Number of Results
1980	1
1981	14
1982	92
1983	244
1984	298
1985	399
1986	386
1987	390
1988	455
1989	482
1990	572
1991	537
1992	600
1993	615
1994	582
1995	715
1996	655
1997	565
1998	621
1999	584
2000	678
2001	690
2002	751
2003	780
2004	867
2005	818
2006	803
2007	879
2008	774
2009	828
2010	845
2011	950
2012	808
2013	759
2014	716
2015	631
2016	548
2017	434
2018	326
2019	320
2020	306
2021	249
2022	147
2023	114
2024	131
2025	105

1

Type I and type III interferon-induced immune response: it's a matter of kinetics and magnitude.

Olagnier D, Hiscott J. Olagnier D, et al. Hepatology. 2014 Apr;59(4):1225-8. doi: 10.1002/hep.26959. Epub 2014 Feb 28. Hepatology. 2014. PMID: 24677190 No abstract available.

2

ELISA-based quantification of type I IFN secretion by irradiated cancer cells.

De Martino M, Daviaud C, Vanpouille-Box C. De Martino M, et al. Methods Cell Biol. 2022;172:163-178. doi: 10.1016/bs.mcb.2022.01.004. Epub 2022 Mar 17. Methods Cell Biol. 2022. PMID: 36064222

3

Wherefore interferon?

Gresser I. Gresser I. J Leukoc Biol. 1997 May;61(5):567-74. doi: 10.1002/jlb.61.5.567. J Leukoc Biol. 1997. PMID: 9129205 Review.

4

USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response.

François-Newton V, Magno de Freitas Almeida G, Payelle-Brogard B, Monneron D, Pichard-Garcia L, Piehler J, Pellegrini S, Uzé G. François-Newton V, et al. PLoS One. 2011;6(7):e22200. doi: 10.1371/journal.pone.0022200. Epub 2011 Jul 14. PLoS One. 2011. PMID: 21779393 Free PMC article.

5

Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures.

Caraccio N, Cuccato S, Pratesi F, Dardano A, Ursino S, Chimenti D, Boldrini L, Materazzi G, Migliorini P, Monzani F. Caraccio N, et al. Thyroid. 2009 Feb;19(2):149-55. doi: 10.1089/thy.2008.0290. Thyroid. 2009. PMID: 19191746

6

Interferons.

Betcher D, Burnham N. Betcher D, et al. J Assoc Pediatr Oncol Nurses. 1989;6(2):43-6. doi: 10.1177/104345428900600237. J Assoc Pediatr Oncol Nurses. 1989. PMID: 2661811 Review. No abstract available.

7

Interferon induction, evasion, and paradoxical roles during SARS-CoV-2 infection.

Chiale C, Greene TT, Zuniga EI. Chiale C, et al. Immunol Rev. 2022 Aug;309(1):12-24. doi: 10.1111/imr.13113. Epub 2022 Jul 1. Immunol Rev. 2022. PMID: 35775361 Free PMC article. Review.

8

Type I interferons: ancient peptides with still under-discovered anti-cancer properties.

Caraglia M, Dicitore A, Marra M, Castiglioni S, Persani L, Sperlongano P, Tagliaferri P, Abbruzzese A, Vitale G. Caraglia M, et al. Protein Pept Lett. 2013 Apr;20(4):412-23. Protein Pept Lett. 2013. PMID: 23016588 Review.

9

Inhibiting cell-to-cell transmission to reach HDV cure: The importance of IFN-α.

Lucifora J, Verrier ER, Baumert TF. Lucifora J, et al. J Hepatol. 2022 Oct;77(4):903-905. doi: 10.1016/j.jhep.2022.07.015. Epub 2022 Aug 8. J Hepatol. 2022. PMID: 35952820 Free article. No abstract available.

10

Interferon-mediated fatigue.

Malik UR, Makower DF, Wadler S. Malik UR, et al. Cancer. 2001 Sep 15;92(6 Suppl):1664-8. doi: 10.1002/1097-0142(20010915)92:6+<1664::aid-cncr1494>3.0.co;2-9. Cancer. 2001. PMID: 11598884 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,726 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,726 results

Results by year